Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06373718 · ClinicalTrials.gov registry record · NA

Sleep Mechanisms Of Regulating Emotions

A NA study of Depression and Insomnia, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06373718: Recruiting NA study of Depression and Insomnia, sponsored by Stanford University.

NCT06373718 is a NA study of Depression and Insomnia that is actively recruiting participants, run by Stanford University. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06373718, a NA study of Depression and Insomnia, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This project is the second phase of a two-phased project investigating the impact of a proven sleep intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I) on engagement of the emotion regulation brain network as a putative mechanistic target.

Primary Outcome

During functional magnetic resonance imaging the Emotion Regulation Network will be engaged by emotional tasks, and circuit activation will be quantified by blood flow in regions of interest.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Insomnia

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-08-12
Est. Completion 2027-06
Phase NA
Stanford University

1,744 total trials

What NCT06373718 shows while recruiting

NCT06373718 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy for Insomnia is the first listed.

NCT06373718 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06373718 about?

NCT06373718 is a clinical study titled "Sleep Mechanisms Of Regulating Emotions". This project is the second phase of a two-phased project investigating the impact of a proven sleep intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I) on engagement of the emotion regulation brain network as a putative mechanistic target.

What is the current status of trial NCT06373718?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-08-12. Estimated completion is 2027-06.

What conditions does trial NCT06373718 study?

This clinical trial studies the following conditions: Depression, Insomnia.

What interventions are being tested in trial NCT06373718?

The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT06373718?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06373718 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06373718's enrollment target sits among peer trials

150 249th of 679 higher than 416 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06373718, the US trial registry maintained by the National Library of Medicine. NCT06373718 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.